
"The procedure is often not fully covered by insurance, with roughly a quarter of employers reporting coverage of IVF for their workers. Context: In February, Trump ordered policy recommendations to reduce the costs for accessing IVF, which can range from $12,000 to $25,000 per cycle. Trump has allied himself with "pro-natalist" policies to encourage a new baby boom and endorsed assisted reproductive services in March when he called himself the "fertilization president.""
"But the administration's involvement has spurred anti-abortion conservatives to call for new guardrails that could greatly limit the use of the treatment. How it works: The procedure is politically fraught, because IVF generally involves the creation of more human embryos than are needed, in order to improve the odds of a pregnancy. Many surplus embryos are discarded - a practice some anti-abortion forces liken to assisted suicide and abortion."
"The February order didn't address Trump's campaign promise to mandate that the government or insurance companies cover the cost of IVF for "all Americans that need it." Trump has been demanding commitments from big drugmakers to lower their U.S. prices by committing to a "most favored nation" policy he laid out in a May executive order. So far, the administration has struck deals with Pfizer and Astra Zeneca. Editor's note: This is a developing story. Please check back for updates."
IVF often lacks full insurance coverage, with roughly one quarter of employers reporting coverage. Policy recommendations were ordered in February to lower IVF costs, which can range from $12,000 to $25,000 per cycle. The administration has promoted pro-natalist measures and publicly endorsed assisted reproductive services. Anti-abortion conservatives have urged new guardrails that could restrict IVF use. IVF typically involves creating extra embryos to improve pregnancy odds, and many surplus embryos are discarded, provoking ethical objections. The February order did not mandate universal IVF coverage. The administration pursued a "most favored nation" pricing approach and struck deals with major drugmakers.
Read at Axios
Unable to calculate read time
Collection
[
|
...
]